Kiora Pharmaceuticals, Inc. (KPRX) Ownership

NASDAQ: KPRXTop holders, insider trades and short interest.

KPRX ownership summary

as of October 18, 2026
Institutions
36.3%
of shares outstanding
Insiders
8.91%
of shares outstanding
Shares outstanding
4.4M
Float
3.9M
shares available to trade
Short interest
0.08%
3,432 shares short
Days to cover
0.25
short interest down 14.6% vs prior month
  • Institutions 36.35%
  • Insiders 8.91%
  • Other investors 54.75%

KPRX top institutional holders

20 largest
Kiora Pharmaceuticals, Inc. top institutional holders
#Holder% of sharesSharesValueChangeReported
1Perceptive Advisors LLC9.91%438K$1.1M+438,471 (0.0%)June 30, 2026
2ADAR1 Capital Management LLC3.80%168K$403,058—June 30, 2026
3Citadel Advisors Llc2.62%116K$278,426+66,478 (+134.2%)June 30, 2026
4Two Sigma Investments LLC2.01%89K$213,101+88,792 (0.0%)June 30, 2026
5Millennium Management LLC1.68%74K$178,085+74,202 (0.0%)June 30, 2026
6HRT FINANCIAL LLC1.32%59K$140,669+58,612 (0.0%)June 30, 2026
7Renaissance Technologies Corp0.67%30K$71,578+29,824 (0.0%)June 30, 2026
8Geode Capital Management, LLC0.60%27K$64,121−21,133 (−44.2%)June 30, 2026
9Vanguard Capital Management, LLC0.45%20K$47,666—June 30, 2026
10Scientech Research LLC0.42%19K$44,990+18,746 (0.0%)June 30, 2026
11Vanguard Fiduciary Trust Co0.29%13K$31,272—June 30, 2026
12LPL Financial Corp0.28%12K$30,000+12,500 (0.0%)June 30, 2026
13Dimensional Fund Advisors, Inc.0.27%12K$29,131+12,138 (0.0%)June 30, 2026
14Northern Trust Corp0.27%12K$28,241+11,767 (0.0%)June 30, 2026
15Jane Street Group LLC0.24%11K$25,476+10,615 (0.0%)June 30, 2026
16UBS Group AG0.04%1,961$4,706+660 (+50.7%)June 30, 2026
17Caitong International Asset Management Co., Limited.0.04%1,813$4,351+1,807 (+30,116.7%)June 30, 2026
18Morgan Stanley - Brokerage Accounts0.03%1,408$3,379—June 30, 2026
19Tower Research Capital LLC0.02%837$2,009−158 (−15.9%)June 30, 2026
20SBI Securities Co Ltd0.01%256$614—June 30, 2026

Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 13 holders added 825K shares and 2 cut 21K.

KPRX top mutual fund and ETF holders

10 largest
Kiora Pharmaceuticals, Inc. top fund holders
#Holder% of sharesSharesValueChangeReported
1Fidelity Extended Market Index0.47%21K$49,915−112 (−0.5%)August 31, 2026
2DFA US Vector Equity I0.09%3,923$9,415—August 31, 2026
3Dimensional US Core Equity 2 ETF0.08%3,510$8,424—September 30, 2026
4Fidelity Series Total Market Index0.08%3,446$8,270—August 31, 2026
5Bridgeway Omni Small-Cap Value N0.05%2,000$4,800—June 30, 2026
6DFA US Sustainability Core 10.04%1,895$4,548—August 31, 2026
7Dimensional US Core Equity 1 ETF0.04%1,574$3,778—September 24, 2026
8DFA US Social Core Equity 2 Portfolio0.03%1,236$2,966—August 31, 2026
9Dimensional US Sustainability Core 1 ETF0.03%1,230$2,952—September 30, 2026
10Fidelity Total Market Index0.02%747$1,793—August 31, 2026

Funds report holdings monthly or quarterly; dates differ by fund.

KPRX insider transactions

latest 6
Kiora Pharmaceuticals, Inc. insider transactions
DateNameTransactionPriceSharesValue
2024-09-10Aron ShapiroBuy$3.603,000$10,800
2024-08-19Lisa Walters-HoffertBuy$3.861,250$4,825
2024-06-14Eric Joseph DanielsBuy$5.291,431$7,570
2024-06-14Melissa ToscaBuy$5.25100$525
2024-06-13Brian M StremBuy$5.003,000$15,000
2024-06-13Erin ParsonsBuy$4.885,260$25,669

Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.

KPRX shares outstanding

Shares outstanding

Year-end shares outstanding, adjusted for splits.

Who owns KPRX

Institutional investors own 36.3% of Kiora Pharmaceuticals's shares and insiders 8.91%. The largest holder is Perceptive Advisors LLC with 9.91% of the shares (438K), as of June 30, 2026. Among the top 20 institutions, 13 added shares and 2 reduced their stake in the latest filings. Short interest is 0.08% of the float, or 0.25 days of average trading volume. The share count rose 35,278.4% since 2014.

Related: KPRX analyst forecast, KPRX key metrics. See the KPRX stock overview for the latest quote and news.

KPRX ownership FAQ

Who owns the most Kiora Pharmaceuticals stock?

The largest shareholders of Kiora Pharmaceuticals are Perceptive Advisors LLC (9.91%), ADAR1 Capital Management LLC (3.80%), Citadel Advisors Llc (2.62%), Two Sigma Investments LLC (2.01%), Millennium Management LLC (1.68%).

What percentage of Kiora Pharmaceuticals is owned by institutions?

Institutions hold 36.3% of Kiora Pharmaceuticals's shares outstanding; insiders hold 8.91%.

Which funds own Kiora Pharmaceuticals?

The largest fund holders of Kiora Pharmaceuticals are Fidelity Extended Market Index (0.47%), DFA US Vector Equity I (0.09%), Dimensional US Core Equity 2 ETF (0.08%), Fidelity Series Total Market Index (0.08%), Bridgeway Omni Small-Cap Value N (0.05%).

What is Kiora Pharmaceuticals's short interest?

3,432 shares of Kiora Pharmaceuticals were sold short, 0.08% of the float; at the average daily volume it would take 0.25 days to cover.

Are insiders buying or selling Kiora Pharmaceuticals?

Of the latest 6 reported insider transactions in Kiora Pharmaceuticals (since June 13, 2024), 6 were purchases and 0 were sales.

How many shares of Kiora Pharmaceuticals are outstanding?

Kiora Pharmaceuticals has 4.4M shares outstanding, of which 3.9M are in the public float.

Biotechnology: ownership